Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30007102HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30012304HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30002720HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30016827HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30074963HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30081640HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30074966HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043907HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043908HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043909HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TCGA Plot Options
Drug Information
GeneSTAT3
DrugBank IDDB16630
Drug NameOPB-111077
Target IDBE0003462
UniProt IDP40763
Regulation Typeinhibitor
PubMed IDs29511132
CitationsTolcher A, Flaherty K, Shapiro GI, Berlin J, Witzig T, Habermann T, Bullock A, Rock E, Elekes A, Lin C, Kostic D, Ohi N, Rasco D, Papadopoulos KP, Patnaik A, Smith L, Cote GM: A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. Oncologist. 2018 Jun;23(6):658-e72. doi: 10.1634/theoncologist.2017-0325. Epub 2018 Mar 6.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL